Brief: Turnstone Biologics to Be Acquired by XOMA for $0.34/Share Plus Contingent Value Right

Xoma Royalty

27/06/2025 12:32

June 27 (Reuters) - Turnstone Biologics Corp TSBX.O:

TURNSTONE BIOLOGICS CORP. ENTERS INTO AGREEMENT TO BE ACQUIRED BY XOMA ROYALTY CORPORATION FOR $0.34 IN CASH PER SHARE PLUS A CONTINGENT VALUE RIGHT

TURNSTONE BIOLOGICS CORP - DEAL VALUED AT $0.34 PER SHARE PLUS CVR

Source text: ID:nGNX6hGWnv

Further company coverage: TSBX.O

 ((Reuters.Briefs@thomsonreuters.com;))